Charles Dumontet

6PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersMedical mycologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 09, 2022
In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti-PD-1/PD-L1 Therapies.

Morgane Denis, Chloé Grasselly, Pierre-Antoine Choffour

|Jan 13, 2021
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma.

Eileen M Boyle, Shayu Deshpande, Ruslana Tytarenko

|Feb 20, 2019
In vitro modulation of multidrug resistance by pregnane steroids and in vivo inhibition of tumour development by 7α-OBz-11α(R)-OTHP-5β-pregnanedione in K562/R7 and H295R cell xenografts.

Ghina Alameh, Agnès Emptoz-Bonneton, Marc Rolland de Ravel

|May 02, 2018
Real life management of patients hospitalized with multiple myeloma in France.

Charles Dumontet, Sandrine Couray-Targe, Marion Teisseire

Pageof 1